Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production | Absci Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production - Absci

04.06.2021

Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production

Endpoints News names Sean McClain, CEO and founder of Absci, to its 20 Under Forty in Biopharma list. Read more.